(S)-1-Ethyl-2-methyl-piperazine → HCID 178462765、化合物
反応式
[C:1]([C:3]1[C:8]([F:9])=[CH:7][C:6]([C:10]2[CH:11]=[N:12][N:13]([C:16]3[CH:24]=[CH:23][C:19]([C:20]([OH:22])=O)=[CH:18][N:17]=3)[C:14]=2[OH:15])=[C:5]([CH3:25])[CH:4]=1)#[N:2].[CH2:26]([N:28]1[CH2:33][CH2:32][NH:31][CH2:30][C@@H:29]1[CH3:34])[CH3:27]>>[CH2:26]([N:28]1[CH2:33][CH2:32][N:31]([C:20]([C:19]2[CH:23]=[CH:24][C:16]([N:13]3[C:14]([OH:15])=[C:10]([C:6]4[C:5]([CH3:25])=[CH:4][C:3]([C:1]#[N:2])=[C:8]([F:9])[CH:7]=4)[CH:11]=[N:12]3)=[N:17][CH:18]=2)=[O:22])[CH2:30][C@@H:29]1[CH3:34])[CH3:27]参加物
3
実験手順
The title compound was prepared in a manner similar to Example 112 using 6-(4-(4-cyano-5-fluoro-2-methylphenyl)-5-hydroxy-1H-pyrazol-1-yl)nicotinic acid and (S)-1-ethyl-2-methylpiperazine. 1H NMR (400 MHz, DMSO-d6) δ ppm 0.95-1.30 (m, 6 H) 2.41 (s, 3 H) 2.79 (dt, J=12.95, 6.54 Hz, 2 H) 2.94-3.10 (m, 2 H) 3.13 (d, J=11.37 Hz, 1 H) 3.23 (dd, J=13.14, 8.34 Hz, 1 H) 3.46 (br. s., 1 H) 3.61-4.25 (m, 2 H) 7.59 (d, J=7.33 Hz, 1 H) 7.91-8.00 (m, 1 H) 8.03 (s, 1 H) 8.30 (d, J=13.14 Hz, 1 H) 8.45-8.57 (m, 2 H); ESI-MS m/z [M+H]+ 449.3.
出典と根拠
- ORDレコード
- ord-bf36b69dfbde427da95db0dd323a923b
- 出典データセット
- uspto-grants-2015_05